Dr. Eugene M Smolens, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 237 N Aberdeen Ave, Wayne, PA 19087 Phone: 610-293-9383 |
Dr. Troels Glysing-jensen, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 237 N Aberdeen Ave, Lifecare Podiatry, Wayne, PA 19087 Phone: 610-293-9383 Fax: 610-293-0409 |
Philip E Bernstein, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 308 N Wayne Ave, Wayne, PA 19087 Phone: 610-688-1682 Fax: 610-688-4708 |
Lifecare Podiatry, P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 237 N Aberdeen Ave, Wayne, PA 19087 Phone: 610-293-9383 Fax: 610-293-0409 |
Paul D Cryan Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 295 Old Eagle School Rd, Wayne, PA 19087 Phone: 610-688-2304 Fax: 610-254-9384 |
David A Bernstein, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 308 N Wayne Ave, Wayne, PA 19087 Phone: 610-688-1682 Fax: 610-688-4708 |
News Archive
Breast cancer patients may be at an increased risk of cardiovascular diseases including heart failure and may benefit from a treatment approach that weighs the benefits of specific therapies against potential damage to the heart, according to a new scientific statement from the American Heart Association published in its journal Circulation.
Fast-track diagnostics, a global leader in the design, development and manufacture of infectious disease detection kits, has released a CE labelled Real-time PCR kit for the detection of the Zaire Ebolavirus – the strain responsible for the current outbreak in West Africa.
Computers can predict the detailed structure of small proteins nearly as well as experimental methods, at least some of the time, according to new studies by Howard Hughes Medical Institute researchers.
Neuroene Therapeutics, a start-up company founded by mitochondrial biologist Sherine S. L. Chan, Ph.D. and medicinal chemist C. James Chou, Ph.D. of the Medical University of South Carolina, has received a $1.5 million NIH Phase II Small Business Innovation Research grant to optimize vitamin K analogues that could improve seizure control in patients with drug-resistant epilepsy.
› Verified 4 days ago